
Sara Elizabeth Townsley
Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1612, 1613 |
| Total Applications | 512 |
| Issued Applications | 97 |
| Pending Applications | 84 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8476640
[patent_doc_number] => 20120276047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/512073
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32959
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512073
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/512073 | FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES | Nov 22, 2010 | Abandoned |
Array
(
[id] => 6007955
[patent_doc_number] => 20110059986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'INTERMITTENT DOSING REGIMEN FOR OVERWEIGHT AND OBESE SUBJECTS'
[patent_app_type] => utility
[patent_app_number] => 12/947960
[patent_app_country] => US
[patent_app_date] => 2010-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5644
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12947960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/947960 | INTERMITTENT DOSING REGIMEN FOR OVERWEIGHT AND OBESE SUBJECTS | Nov 16, 2010 | Abandoned |
Array
(
[id] => 9582241
[patent_doc_number] => 08772244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Tubulin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/509060
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 4289
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509060
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509060 | Tubulin inhibitors | Nov 11, 2010 | Issued |
Array
(
[id] => 5930630
[patent_doc_number] => 20110040266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'ANTI-INSOMNIA COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/912261
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4949
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20110040266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912261 | ANTI-INSOMNIA COMPOSITIONS AND METHODS | Oct 25, 2010 | Abandoned |
Array
(
[id] => 10147927
[patent_doc_number] => 09180192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'
[patent_app_type] => utility
[patent_app_number] => 13/503644
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28172
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503644 | mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Oct 21, 2010 | Issued |
Array
(
[id] => 8430928
[patent_doc_number] => 20120252803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS'
[patent_app_type] => utility
[patent_app_number] => 13/502815
[patent_app_country] => US
[patent_app_date] => 2010-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74568
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502815 | COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS | Oct 17, 2010 | Abandoned |
Array
(
[id] => 6196685
[patent_doc_number] => 20110028443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'LIGANDS FOR NEMATODE NUCLEAR RECEPTORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/905459
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 23866
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028443.pdf
[firstpage_image] =>[orig_patent_app_number] => 12905459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/905459 | LIGANDS FOR NEMATODE NUCLEAR RECEPTORS AND USES THEREOF | Oct 14, 2010 | Abandoned |
Array
(
[id] => 6127765
[patent_doc_number] => 20110086830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'METAL COMPLEXES OF N-HETEROCYCLIC CARBENES'
[patent_app_type] => utility
[patent_app_number] => 12/902807
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16587
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086830.pdf
[firstpage_image] =>[orig_patent_app_number] => 12902807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/902807 | Metal complexes of N-heterocyclic carbenes | Oct 11, 2010 | Issued |
Array
(
[id] => 5993556
[patent_doc_number] => 20110015209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery'
[patent_app_type] => utility
[patent_app_number] => 12/923504
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14808
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12923504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/923504 | Sigma ligands for neuronal regeneration and functional recovery | Sep 23, 2010 | Abandoned |
Array
(
[id] => 8382312
[patent_doc_number] => 20120225949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 13/389781
[patent_app_country] => US
[patent_app_date] => 2010-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15399
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389781 | COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER | Aug 12, 2010 | Pending |
Array
(
[id] => 7757120
[patent_doc_number] => 20120029042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'CLONIDINE FOR TREATMENT OF BONE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/847075
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12847075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/847075 | CLONIDINE FOR TREATMENT OF BONE CANCER | Jul 29, 2010 | Abandoned |
Array
(
[id] => 8186474
[patent_doc_number] => 20120115778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2'
[patent_app_type] => utility
[patent_app_number] => 13/383050
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 21700
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115778.pdf
[firstpage_image] =>[orig_patent_app_number] => 13383050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383050 | Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2 | Jul 14, 2010 | Abandoned |
Array
(
[id] => 8465766
[patent_doc_number] => 20120270934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'PROSTACYCLIN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/381419
[patent_app_country] => US
[patent_app_date] => 2010-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25049
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 61
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381419
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/381419 | PROSTACYCLIN DERIVATIVES | Jul 1, 2010 | Abandoned |
Array
(
[id] => 8477825
[patent_doc_number] => 20120277233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Pyridyl-Triazine Inhibitors of Hedgehog Signaling'
[patent_app_type] => utility
[patent_app_number] => 13/377003
[patent_app_country] => US
[patent_app_date] => 2010-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12926
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377003
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/377003 | Pyridyl-Triazine Inhibitors of Hedgehog Signaling | Jun 7, 2010 | Abandoned |
Array
(
[id] => 6515681
[patent_doc_number] => 20100216795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'TNIK INHIBITOR AND THE USE'
[patent_app_type] => utility
[patent_app_number] => 12/766513
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28980
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216795.pdf
[firstpage_image] =>[orig_patent_app_number] => 12766513
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/766513 | TNIK INHIBITOR AND THE USE | Apr 22, 2010 | Abandoned |
Array
(
[id] => 7768234
[patent_doc_number] => 20120035273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING GLYCEROL, WHITE SOFT PARAFFIN AND LIQUID PARAFFIN FOR THE TREATMENT OF UREMIC XEROSIS AND/OR PRURITUS'
[patent_app_type] => utility
[patent_app_number] => 13/264653
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7922
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035273.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264653
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264653 | PHARMACEUTICAL COMPOSITION COMPRISING GLYCEROL, WHITE SOFT PARAFFIN AND LIQUID PARAFFIN FOR THE TREATMENT OF UREMIC XEROSIS AND/OR PRURITUS | Apr 15, 2010 | Abandoned |
Array
(
[id] => 6505942
[patent_doc_number] => 20100260858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'DRUG DELIVERY COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/757005
[patent_app_country] => US
[patent_app_date] => 2010-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12464
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260858.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757005
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757005 | DRUG DELIVERY COMPOSITION | Apr 7, 2010 | Abandoned |
Array
(
[id] => 11269182
[patent_doc_number] => 20160331729
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-11-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/722429
[patent_app_country] => US
[patent_app_date] => 2010-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 45329
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12722429
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722429 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS | Mar 10, 2010 | Abandoned |
Array
(
[id] => 11269182
[patent_doc_number] => 20160331729
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-11-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/722429
[patent_app_country] => US
[patent_app_date] => 2010-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 45329
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12722429
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722429 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS | Mar 10, 2010 | Abandoned |
Array
(
[id] => 6635269
[patent_doc_number] => 20100226873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Hemostatic Composition with Magnetite'
[patent_app_type] => utility
[patent_app_number] => 12/719434
[patent_app_country] => US
[patent_app_date] => 2010-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3850
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12719434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/719434 | Hemostatic Composition with Magnetite | Mar 7, 2010 | Abandoned |